The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis

Journal of Infection - Tập 81 - Trang e13-e20 - 2020
Zhenwei Yang1,2, Jialong Liu1,2, Yunjiao Zhou1,2, Xixian Zhao1,2, Qiu Zhao1,2, Jing Liu1,2
1Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
2Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Diseases, Wuhan 430071, China

Tài liệu tham khảo

Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N Engl J Med, 382, 727, 10.1056/NEJMoa2001017

Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A., et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group. 2020:2020.02.07.937862.

WHO. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February2020. Available from:https://www.who.int/zh/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020.

He F., Deng Y., Li W.Coronavirus disease 2019 (COVID-19): what we know?J Med Virol. 2020 Mar 14. PubMed PMID: 32170865. Epub 2020/03/15. eng.

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet (London, England), 395, 497, 10.1016/S0140-6736(20)30183-5

Chan, 2020, A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster, Lancet (London, England), 395, 514, 10.1016/S0140-6736(20)30154-9

WHO. WHO Director-General's opening remarks at the Mission briefing on COVID-19 - 19 March 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-mission-briefing-on-covid-19---19-march-2020.

Lu, 2020, Drug treatment options for the 2019-new coronavirus (2019-nCoV), Biosci Trends, 14, 69, 10.5582/bst.2020.01020

Cruz-Topete, 2015, One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids, NeuroImmuno Modul, 22, 20, 10.1159/000362724

Yam, 2007, Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong, J Infect, 54, 28, 10.1016/j.jinf.2006.01.005

Arabi, 2018, Corticosteroid therapy for critically ill patients with middle east respiratory syndrome, Am J Respir Crit Care Med, 197, 757, 10.1164/rccm.201706-1172OC

Stang, 2010, Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses, Eur J Epidemiol, 25, 603, 10.1007/s10654-010-9491-z

Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA, 10.1001/jama.2020.1585

Alfaraj, 2019, Clinical predictors of mortality of middle east respiratory syndrome coronavirus (mers-cov) infection: a cohort study, Travel Med Infect Dis, 29, 48, 10.1016/j.tmaid.2019.03.004

Jia, 2009, [Dose of glucocorticosteroids in the treatment of severe acute respiratory syndrome], J Southern Medical University, 29, 2284

Chen, 2006, Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience, Chest, 129, 1441, 10.1378/chest.129.6.1441

Xu, 2005, [Analysis of corticosteroid therapy in 453 patients with SARS], Chin J Hospital Pharm, 58

Wang, 2005, [Evaluating the effects of different treatments on severe acute respira tory syndrome], Shanxi Med J, 270

Ding, 2005, [Retrospective analysis of the glucocorticoid treatment in 409 patients with severe acute respiratory syndrome], Chin J General Pract, 193

Auyeung, 2005, The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study, J Infect, 51, 98, 10.1016/j.jinf.2004.09.008

Wang, 2004, [Investigation of adverse reactions to glucocorticods in 460 SARS patients], Adv Drug React J, 78

Wang, 2004, [Effects and adverse drug reactions of mtrisone in the treatment of patients with severe acute respiratory syndrome], Chin J Clin Pharmacol Therap, 992

Qin, 2003, [A clinical investigation in 83 cases with severe acute respiratory syndrome], Chin J Respir Critic Care Med, 15

He, 2003, [Adverse effects associated with corticosteroids therapy in 57 SARS case], Adv Drug React J, 374

Russell, 2020, Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury, Lancet (London, England), 395, 473, 10.1016/S0140-6736(20)30317-2

Shang, 2020, On the use of corticosteroids for 2019-nCoV pneumonia, Lancet (London, England), 395, 683, 10.1016/S0140-6736(20)30361-5

Xu, 2020, Pathological findings of COVID-19 associated with acute respiratory distress syndrome, The Lancet Respiratory medicine, 10.1016/S2213-2600(20)30076-X

Montón, 1999, Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study, Eur Respir J, 14, 218, 10.1034/j.1399-3003.1999.14a37.x

Gonzalo, 1993, Glucocorticoid-mediated control of the activation and clonal deletion of peripheral T cells in vivo, J Exp Med, 177, 1239, 10.1084/jem.177.5.1239

Wilkinson, 2012, Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans, Nat Med, 18, 274, 10.1038/nm.2612

Lee, 2004, Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients, J Clin Virol, 31, 304, 10.1016/j.jcv.2004.07.006

Ling, 2020, Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients, Chin Med J (Engl), 10.1097/CM9.0000000000000774

Stockman, 2006, SARS: systematic review of treatment effects, PLoS Med, 3, e343, 10.1371/journal.pmed.0030343

Ni, 2019, The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis, Crit Care, 23, 99-, 10.1186/s13054-019-2395-8

Zhao, 2017, Steroid therapy and the risk of osteonecrosis in SARS patients: a dose-response meta-analysis, Osteoporosis Int, 28, 1027, 10.1007/s00198-016-3824-z

Thông tin
Thông tin xuất bản

Journal of Infection

Tập 81

e13-e20

Thông tin tác giả